CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Daiichi Sankyo
Daiichi Sankyo logo

Daiichi Sankyo

Daiichi Sankyo Inc.: Global pharmaceutical leader offering innovative therapies for heart and blood pressure conditions.

Basking Ridge, NJ, US🇺🇸
Founded
1866
Overview
M & A
Compare
Fundraising
Employees
Library

Daiichi Sankyo Inc. is a global pharmaceutical leader dedicated to developing innovative therapies for heart and blood pressure conditions. The company offers a range of medicines addressing high and low blood pressure, heart-related events, and other related diseases. With a strong focus on patient-centric initiatives, Daiichi Sankyo serves customers worldwide, aiming to improve health outcomes through advanced research and development.

Daiichi Sankyo has achieved significant milestones in the pharmaceutical industry, including a robust pipeline of new treatments and a commitment to sustainability and corporate governance. The company's impact is reflected in its global reach and the successful introduction of life-saving medications. Notable achievements include advancements in cardiovascular therapies and a consistent emphasis on patient-centric care.

Daiichi Sankyo - M & A Snapshot

Open M & A

  • Ambit Biosciences

    Acquired by Daiichi Sankyo • Undisclosed • Nov 4, 2014

Daiichi Sankyo - Similar Companies

Eisai Co. logo

Eisai Co.

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Novartis Pharma logo

Novartis Pharma

Shionogi & Co. logo

Shionogi & Co.

ONO Pharmaceutical logo

ONO Pharmaceutical

Otsuka Holdings Co. logo

Otsuka Holdings Co.

otsuka.com

Astellas Pharma logo

Astellas Pharma

astellas.com

Sanofi logo

Sanofi

sanofi.com

Kyowa Kirin Co. logo

Kyowa Kirin Co.

kyowakirin.com

Sumitomo Pharma Co. logo

Sumitomo Pharma Co.

Haisco logo

Haisco

Zenyaku Kogyo Co. logo

Zenyaku Kogyo Co.

zenyaku.co.jp

GNI Group logo

GNI Group

gnipharma.com

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

Daiichi Sankyo - Quick Facts

Who are Daiichi Sankyo's competitors?

Companies similar to Daiichi Sankyo include Eisai Co., Bayer Pharmaceuticals, Taiho Pharmaceutical Co. and Novartis Pharma.

When was Daiichi Sankyo founded?

Daiichi Sankyo was founded in 1866.

Where is Daiichi Sankyo's headquarters located?

Daiichi Sankyo's headquarters is located in Basking Ridge, NJ, US.

How many employees does Daiichi Sankyo have?

Daiichi Sankyo has 10,000 employees as of Feb 10, 2024.

Daiichi Sankyo - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research